Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

Background Whether acetazolamide, a carbonic anhydrase inhibitor that reduces proximal
tubular sodium reabsorption, can improve the efficiency of loop diuretics, potentially leading …

Aims To evaluate whether the addition of hydrochlorothiazide (HCTZ) to intravenous
furosemide is a safe and effective strategy for improving diuretic response in acute heart …

Cardiorenal syndrome encompasses a spectrum of disorders involving both the heart and
kidneys in which acute or chronic dysfunction in 1 organ may induce acute or chronic …

The vast majority of acute heart failure episodes are characterized by increasing symptoms
and signs of congestion with volume overload. The goal of therapy in those patients is the …

Aims Inhibition of sodium–glucose co‐transporter 2 (SGLT2) reduces the risk of death and
heart failure (HF) admissions in patients with chronic HF. However, safety and clinical …

Expansion of extracellular fluid volume is central to the pathophysiology of heart failure.
Increased extracellular fluid leads to elevated intracardiac filling pressures, resulting in a …

Measurement of natriuresis has been suggested as a reliable, easily obtainable biomarker
for assessment of the response to diuretic treatment in patients with acute heart failure …